Pharmaceuticals

Projected Growth of the Global Thrombophilia Market to Reach $24.57 Billion by 2029

December 3, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the thrombophilia market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Thrombophilia Market By The End Of 2029?

The thrombophilia market size has demonstrated robust growth in recent years. It is projected to expand from $17.03 billion in 2024 to $18.18 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.7%. The expansion observed historically can be attributed to factors including heightened awareness, ongoing research and development in anticoagulant therapies, an aging population, advancements in genetic research, and an increased incidence of thrombotic disorders.

The thrombophilia market is anticipated to experience robust expansion over the coming years. Its valuation is projected to reach $24.57 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.8%. This projected growth is driven by factors such as personalized medicine, the introduction of new therapies, the incorporation of artificial intelligence, evolving healthcare policies and regulations, and enhanced patient education and empowerment. Key developments shaping the market during this period encompass advancements in technology, the broadening application of telemedicine, an increase in incidence rates, progress in biopharmaceutical research, and joint research efforts.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9439&type=smp

Which Business Drivers Are Underpinning The Growth Of The Thrombophilia Market?

The increasing elderly population is anticipated to propel the growth of the thrombophilia market going forward. The elderly population refers to individuals aged 65 and up, where the proportion of the dependent population is determined as the total elderly and youth population expressed as a ratio of the total population. Thrombophilic risk factors are prevalent in older adults, allowing for the identification of a demographic at risk for poor clinical outcomes; hence, the rise in the elderly population will boost the market as it creates demand for thrombophilia drugs. For instance, according to data released by America’s Health Rankings, a US-based organization evaluating health outcomes, in 2022, more than 56 million adults aged 65 and older accounted for approximately 16.9% of the total US population. This number of older people is expected to surpass 73.1 million by 2030. Therefore, the growth of the thrombophilia market is being driven by the increase in the elderly population.

What Are The Principal Segment Types In The Thrombophilia Market?

The thrombophilia market covered in this report is segmented –

1) By Type: Factor V Leiden, Prothrombin 20210, Antiphospholipid Syndrome, Other Type

2) By Drugs: Heparin, Warfarin, Other Drugs

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration

4) By End-Users: Hospitals, Homecare, Specialty Centers, Other End Users

Subsegments:

1) By Factor V Leiden: Genetic Testing, Anticoagulant Therapy

2) By Prothrombin 20210: Genetic Testing, Anticoagulant Therapy

3) By Antiphospholipid Syndrome: Antiphospholipid Antibody Testing, Anticoagulant Therapy

4) By Other Types: Protein C Deficiency, Protein S Deficiency, Antithrombin III Deficiency, Other Genetic Conditions

How Are Industry Trends Steering The Expansion Of The Thrombophilia Market?

A prominent trend garnering attention in the thrombophilia market is the advancement of technology. Companies active in this sector are innovating new technologies to maintain their competitive standing. As an illustration, during May 2023, the University of California, San Diego, saw its researchers create Eloctate, a revolutionary technology poised to redefine hemophilia treatment. This novel methodology employs a unique fusion protein, considerably boosting the stability and circulatory half-life of coagulation factors. The researchers’ goal, by integrating this technology with current treatments, is to formulate extended-duration medications, reducing administration frequency and subsequently enhancing patient adherence and overall quality of life.

Which Companies Are Contributing Significantly To The Thrombophilia Market Growth?

Major companies operating in the thrombophilia market include Pfizer Inc., F. Hoffmann-La Roche Limited, Changzhaou Qianhong Bio-pharma Co. Limited, Fresenius Kabi AG, Hebei Changshan Biochemical Pharmaceutical Co. Limited, Hikma Pharmaceuticals PLC., Novartis AG, Shanghai Fosun Pharmaceutical (Group) Co. Ltd., Shenzhen Hepalink Pharmaceutical Group Co. Limited, Teva Pharmaceutical Industries Limited, Yino Pharma Limited, Sanofi SA, Eisai Co. Limited, Boehringer Ingelheim GmbH, Instrumentation Laboratory SpA, Johnson & Johnson, Laurus Lab, Bristol-Myers Squibb, Roche, Abbott, C. H. Boehringer Sohn, Portola Pharmaceuticals, Daiichi Sankyo, Bayer Group, GlaxoSmithKline plc, CSL Behring

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/thrombophilia-global-market-report

Which Region Offers The Most Opportunity For Thrombophilia Market Expansion?

North America was the largest region in the thrombophilia market in 2024. The regions covered in the thrombophilia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=9439&type=smp

Browse Through More Reports Similar to the Global Thrombophilia Market 2025, By The Business Research Company

Anemia And Other Blood Disorder Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

Drugs For Hormonal Replacement Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-hormonal-replacement-therapy-global-market-report

Biosimilar Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biosimilar-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795